Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Chronic Obstructive Pulmonary Disease (COPD) Companies

Dedicated to respiratory health, Chronic Obstructive Pulmonary Disease (COPD) companies lead in research, development, and distribution of solutions to manage COPD. These organizations provide a range of products and services to enhance the quality of life for individuals facing this chronic respiratory condition, focusing on innovation and patient well-being.

Latest Chronic Obstructive Pulmonary Disease Companies Update

Latest Chronic Obstructive Pulmonary Disease Treatment Companies Update

Teva's ArmonAir Digihaler approved this inhalation powder device with built-in sensors and a companion app in February 2022, aiming for better medication adherence in COPD patients.

GlaxoSmithKline's Trelegy Ellipta Launched in India in April 2022, this once-daily single-inhaler triple therapy offers a convenient option for COPD patients requiring multiple medications.

NextCure's VSTM-1 Targeting Antibody promising therapy in Phase 2 clinical trials aims to treat inflammatory lung diseases like COPD by activating an immune cell protein.

Multiple clinical trials underway Several companies are exploring novel drug targets and treatment approaches for COPD, focusing on improved symptom management, disease progression prevention, and potential cures.

List of Chronic Obstructive Pulmonary Disease Treatment Key Companies in the Market

AstraZeneca (UK)

Abbott Laboratories (US)

Dr. Reddy’s Laboratories Ltd (India)

GlaxoSmithKline (UK)

F. Hoffmann-La Roche Ltd (Switzerland)

Almirall (Spain)

Boehringer Ingelheim (Germany)

Pfizer Inc. (US)

Novartis AG (Switzerland)

Astellas Pharma (Japan)

Chronic Obstructive Pulmonary Disease (COPD) Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.